Header Logo

Connection

CHENG CAMERON YIN to Male

Back to Details
This is a "connection" page, showing publications CHENG CAMERON YIN has written about Male.
CHENG CAMERON YIN
Connection Strength
0.415
Male
  1. STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia. Haematologica. 2024 06 01; 109(6):1825-1835.
    View in: PubMed
    Score: 0.029
  2. Mitochondrial (mt)DNA-cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling promotes pyroptosis of macrophages via interferon regulatory factor (IRF)7/IRF3 activation to aggravate lung injury during severe acute pancreatitis. Cell Mol Biol Lett. 2024 Apr 27; 29(1):61.
    View in: PubMed
    Score: 0.029
  3. A novel mutation in HAUS7 results in severe oligozoospermia in two brothers. Gene. 2018 Jan 10; 639:106-110.
    View in: PubMed
    Score: 0.018
  4. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases. Mod Pathol. 2015 Jun; 28(6):787-98.
    View in: PubMed
    Score: 0.015
  5. Rearrangement and expression of the immunoglobulin ?-chain gene in human myeloid cells. Cell Mol Immunol. 2014 Jan; 11(1):94-104.
    View in: PubMed
    Score: 0.014
  6. Double-hit of FLT3 gene in a fatal case of acute myemonocytic leukaemia. J Clin Pathol. 2013 Sep; 66(9):826-9.
    View in: PubMed
    Score: 0.013
  7. Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol. 2013 Jan; 37(1):14-23.
    View in: PubMed
    Score: 0.013
  8. Immunoglobulin gamma heavy chain gene with somatic hypermutation is frequently expressed in acute myeloid leukemia. Leukemia. 2013 Jan; 27(1):92-9.
    View in: PubMed
    Score: 0.013
  9. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases. Hum Pathol. 2012 Sep; 43(9):1436-43.
    View in: PubMed
    Score: 0.012
  10. Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53. Cancer. 2012 Jun 01; 118(11):2879-88.
    View in: PubMed
    Score: 0.012
  11. The identification of risk factors for critically ill patients with acute fever and formulation of activation criteria to alert outpatient clinic doctors. J Eval Clin Pract. 2012 Aug; 18(4):721-6.
    View in: PubMed
    Score: 0.012
  12. The identification of risk factors for infectious patients with acute fever and formulation of activation criteria to alert outpatient clinic doctors. J Eval Clin Pract. 2010 Dec; 16(6):1248-53.
    View in: PubMed
    Score: 0.011
  13. Immunohistochemical profile and fluorescence in situ hybridization analysis of diffuse large B-cell lymphoma in northern China. Arch Pathol Lab Med. 2010 May; 134(5):759-65.
    View in: PubMed
    Score: 0.011
  14. An outbreak of angiostrongyliasis cantonensis in Beijing. J Parasitol. 2010 Apr; 96(2):377-81.
    View in: PubMed
    Score: 0.011
  15. del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia. Cancer Genet Cytogenet. 2009 Jul; 192(1):18-23.
    View in: PubMed
    Score: 0.010
  16. Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical morphologic features and unmutated IgVH genes. Am J Clin Pathol. 2009 May; 131(5):663-70.
    View in: PubMed
    Score: 0.010
  17. Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma. Mod Pathol. 2007 Jan; 20(1):1-7.
    View in: PubMed
    Score: 0.009
  18. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy. Cancer. 2006 Apr 15; 106(8):1730-8.
    View in: PubMed
    Score: 0.008
  19. Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia. Am J Clin Pathol. 2005 Jun; 123(6):840-8.
    View in: PubMed
    Score: 0.008
  20. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein. Am J Clin Pathol. 2005 Apr; 123(4):594-602.
    View in: PubMed
    Score: 0.008
  21. t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia. Am J Clin Pathol. 2004 Jun; 121(6):836-42.
    View in: PubMed
    Score: 0.007
  22. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma. Mod Pathol. 2013 Oct; 26(10):1338-45.
    View in: PubMed
    Score: 0.007
  23. TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature ovarian failure model mice. Nat Commun. 2022 02 17; 13(1):914.
    View in: PubMed
    Score: 0.006
  24. Non-coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis. Am J Hematol. 2022 03 01; 97(3):E100-E102.
    View in: PubMed
    Score: 0.006
  25. Noninvasive prenatal diagnosis for Duchenne muscular dystrophy based on the direct haplotype phasing. Prenat Diagn. 2020 07; 40(8):918-924.
    View in: PubMed
    Score: 0.005
  26. Subchromosomal anomalies in small for gestational-age fetuses and newborns. Arch Gynecol Obstet. 2019 09; 300(3):633-639.
    View in: PubMed
    Score: 0.005
  27. Whole-exome sequencing as a powerful tool for identifying genetic causes in a patient with POLG-related disorders and phenylketonuria. J Int Med Res. 2019 Mar; 47(3):1387-1394.
    View in: PubMed
    Score: 0.005
  28. Dissemination of lymphocytic choriomeningitis virus from the gastric mucosa requires G protein-coupled signaling. J Virol. 1998 Nov; 72(11):8613-9.
    View in: PubMed
    Score: 0.005
  29. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis. Am J Surg Pathol. 2016 Feb; 40(2):253-61.
    View in: PubMed
    Score: 0.004
  30. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma. Am J Surg Pathol. 2015 Sep; 39(9):1250-8.
    View in: PubMed
    Score: 0.004
  31. B-Lymphoblastic Leukemia in Patients With Chronic Lymphocytic Leukemia: A Report of Four Cases. Am J Clin Pathol. 2015 Aug; 144(2):333-40.
    View in: PubMed
    Score: 0.004
  32. [Combined antitumor effect of tumor-infiltrating lymphocytes and tumor necrosis factor alpha]. Zhonghua Bing Li Xue Za Zhi. 1995 Jun; 24(3):162-4.
    View in: PubMed
    Score: 0.004
  33. Lymphomatous variant of hairy cell leukaemia: a distinctive presentation mimicking low-grade B-cell lymphoma. Histopathology. 2015 Nov; 67(5):740-5.
    View in: PubMed
    Score: 0.004
  34. Clinical significance of acquired cytogenetic clones in patients with treated follicular lymphoma. Clin Lymphoma Myeloma Leuk. 2015 May; 15(5):262-9.
    View in: PubMed
    Score: 0.004
  35. Isolated +15 in bone marrow: disease-associated or a benign finding? Leuk Res. 2015 Jan; 39(1):72-6.
    View in: PubMed
    Score: 0.004
  36. Clinically silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasms. Leuk Res. 2014 Aug; 38(8):896-900.
    View in: PubMed
    Score: 0.004
  37. Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma. Ann Diagn Pathol. 2014 Aug; 18(4):203-9.
    View in: PubMed
    Score: 0.004
  38. Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy. Leukemia. 2014 Apr; 28(4):958-61.
    View in: PubMed
    Score: 0.004
  39. Clinicopathologic features of CD5-positive nodal marginal zone lymphoma. Am J Clin Pathol. 2013 Nov; 140(5):693-700.
    View in: PubMed
    Score: 0.003
  40. B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease. Mod Pathol. 2014 Mar; 27(3):382-9.
    View in: PubMed
    Score: 0.003
  41. CXC chemokine receptor 4 expression, CXC chemokine receptor 4 activation, and wild-type nucleophosmin are independently associated with unfavorable prognosis in patients with acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2013 Dec; 13(6):686-92.
    View in: PubMed
    Score: 0.003
  42. Metastatic splenic angiosarcoma presenting with thrombocytopenia and bone marrow fibrosis mimicking idiopathic thrombocytopenic purpura and primary myelofibrosis: a diagnostic challenge. Clin Lymphoma Myeloma Leuk. 2013 Oct; 13(5):629-33.
    View in: PubMed
    Score: 0.003
  43. CD4(-)/CD8(-) variant of T-cell large granular lymphocytic leukemia or hepatosplenic T-cell lymphoma: a clinicopathologic dilemma. Clin Lymphoma Myeloma Leuk. 2013 Oct; 13(5):610-3.
    View in: PubMed
    Score: 0.003
  44. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q). Cancer Genet. 2013 Jan-Feb; 206(1-2):42-6.
    View in: PubMed
    Score: 0.003
  45. Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia. Leuk Lymphoma. 2013 Jan; 54(1):138-44.
    View in: PubMed
    Score: 0.003
  46. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome. Am J Clin Pathol. 2012 Jul; 138(1):146-52.
    View in: PubMed
    Score: 0.003
  47. Clinical impact of change of FLT3 mutation status in acute myeloid leukemia patients. Mod Pathol. 2012 Oct; 25(10):1405-12.
    View in: PubMed
    Score: 0.003
  48. Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity. Leuk Lymphoma. 2012 Sep; 53(9):1839-41.
    View in: PubMed
    Score: 0.003
  49. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome. Mod Pathol. 2012 Jan; 25(1):145-56.
    View in: PubMed
    Score: 0.003
  50. Chromosome 20q deletion: a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remission. Am J Clin Pathol. 2011 Mar; 135(3):391-7.
    View in: PubMed
    Score: 0.003
  51. Refractory anemia with ring sideroblasts associated with marked thrombocytosis: a mixed group exhibiting a spectrum of morphologic findings. Am J Clin Pathol. 2011 Mar; 135(3):398-403.
    View in: PubMed
    Score: 0.003
  52. Trisomy 14 as a sole chromosome abnormality is associated with older age, a heterogenous group of myeloid neoplasms with dysplasia, and a wide spectrum of disease progression. J Biomed Biotechnol. 2010; 2010:365318.
    View in: PubMed
    Score: 0.003
  53. Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome. Arch Pathol Lab Med. 2010 Jul; 134(7):1010-5.
    View in: PubMed
    Score: 0.003
  54. HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis. Mod Pathol. 2010 Mar; 23(3):381-91.
    View in: PubMed
    Score: 0.003
  55. Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors. Cancer. 2008 Sep 01; 113(5):985-94.
    View in: PubMed
    Score: 0.002
  56. MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis. Br J Haematol. 2008 Jul; 142(1):36-44.
    View in: PubMed
    Score: 0.002
  57. Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis. Leukemia. 2008 Jun; 22(6):1295-8.
    View in: PubMed
    Score: 0.002
  58. Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors. Blood. 2007 Dec 01; 110(12):4005-11.
    View in: PubMed
    Score: 0.002
  59. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia. Cancer Genet Cytogenet. 2006 Apr 01; 166(1):82-5.
    View in: PubMed
    Score: 0.002
  60. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases. Am J Clin Pathol. 2005 Nov; 124(5):807-14.
    View in: PubMed
    Score: 0.002
  61. The lymphocytosis-promoting agent pertussis toxin affects virus burden and lymphocyte distribution in the SIV-infected rhesus macaque. AIDS Res Hum Retroviruses. 1997 Jan 01; 13(1):87-95.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.